Steven Favaloro, incoming Genezen CEO (L) and Mark Womack, incoming BioCina CEO
Contract manufacturers BioCina and Genezen name new CEOs
A pair of CDMOs are bringing in new CEOs.
Taking the helm at BioCina is Mark Womack. According to his LinkedIn profile, Womack has been in leadership positions at several contract manufacturers. His career spans more than 30 years, including roles such as CEO of the contract manufacturer KBI Biopharma and Selexis SA. Before that, he was CEO of Stelis Biopharma and chief business officer of Seattle-based manufacturer AGC Biologics.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters